CVS Health Corp. (CVS)
NASDAQ • Healthcare
November 20, 2026 at 21:00 UTC
Metrics Over Time
Where the Money Goes
Q3 2026In plain terms: out of every $100 in revenue, CVS Health Corp. keeps $2 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Feb 9
in 80 daysQ1 2027% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
CVS Health beat expectations on both the top and bottom line in the third fiscal quarter of 2026, which it reported November 4, 2026, with revenue of $108.399 billion topping the $104.721 billion estimate (+3.5%) and adjusted EPS of $2.09 topping the $1.65 estimate (+26.7%). Revenue rose ~5% year over year to about $108.4 billion, up from roughly $102.9 billion a year ago, reflecting results across its Health Care Benefits, pharmacy benefits, and retail pharmacy and clinic operations. Profitability ran at a gross margin of roughly 14% and an operating margin of about 3%, with operating income around $3.6 billion and net income about $2.2 billion, swinging from a net loss of roughly $4.0 billion a year ago. CVS generated operating cash flow of about $4.7 billion during the quarter and paid roughly $853 million in dividends. For the next period, consensus calls for EPS of $1.25 on revenue of $107.207 billion.
About CVS Health Corp.
CVS Health Corporation (NYSE: CVS) is a U.S. healthcare company that combines insurance, pharmacy benefits, and retail pharmacy and clinic operations. In FY2025, it generated $402.1 billion in revenue. Its business spans managed care, prescription fulfillment, and consumer health products within the healthcare plans and services market.
Today's Snapshot
CVS closed 1% higher at 80.87, while its sector was flat. Volume was about two-thirds of its usual level.
Trading Volume
Below 10d avg (12.5M)
8.3M
vs S&P 500 Today
Strong Outperformance
+4.53%
Updated: November 20, 2026 at 21:14 UTC
CVS Headlines
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$84.59 - $90.62Sell
- RSI (14)36.71Neutral
- Stochastic %K (14, 3, 3)23.41Neutral
- MACD Level (12, 26)-1.94Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.